Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
about
Role of Dose Intensification for Salvage Radiation Therapy after Radical ProstatectomyFROGG high-risk prostate cancer workshop: patterns of practice and literature review. Part II post-radical prostatectomyLong-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy.The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy.Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomyRefining the American Urological Association and American Society for Radiation Oncology guideline for adjuvant radiotherapy after radical prostatectomy using the pathologic Gleason score.Radiotherapy in the management of prostate cancer after radical prostatectomy.Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy.The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study.Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy.[Radiation with additional antiandrogen therapy in recurrent prostate cancer].Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes.Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and ChallengesContemporary role of postoperative radiotherapy for prostate cancer
P2860
Q26765872-89DDD3E4-E595-40C0-BDDE-5CB6C484BCCAQ26827690-76FC0C4C-F993-4235-BF39-6D5A5D4C5646Q34325482-0432F410-F3AA-4CDB-B22F-137583981176Q37033549-7F0C7282-FCC3-4433-946F-68DF23FB5F3DQ37213044-669254D0-A8BF-4AB3-A561-38AE9FE03D32Q37536842-020B5DE5-9195-4B43-9494-44B2D6FC4C86Q37581405-C33EBB2A-8B30-4EC3-9E4B-03043B5AA61AQ38104412-7A76DB67-8415-4A38-9244-4BF9864D2D00Q38877792-69B3C459-0867-4CEB-A44C-608FF13293B0Q41336766-54900746-0855-4482-9B43-5E41ECF3EFAEQ41435839-F6A6EF03-C8A3-4571-A6D3-D098C4F12BF7Q46689552-C7D8CB13-F4B0-4B59-9E56-C95EF21C91A0Q47826406-3BCD750B-C56E-406B-86C3-5D6457B7D76FQ50083626-8D4C8E0F-4331-4300-8E67-68E70ADBA3E9Q50861919-2D6F73D4-303A-44CF-ADED-586B4214A9EEQ53118153-3F68D7B6-2794-4C1F-8B2C-EC80F73FDE95Q53260798-8BE3FD4F-FBEF-42D6-AE59-DD4A0E918F05Q53300061-E61910C3-79B6-4050-8E2B-CC459BF36A5FQ54130488-5B18C5B0-DC81-47D9-8083-0CE7AF500C91Q55660188-14CCA8BF-7DC8-4923-BEDB-C1C8D16D2B0FQ57107208-17636B82-47F4-4FD0-AF00-43BED57BF633Q57112410-8C20D932-FD28-4934-8DF3-594903ED8C4B
P2860
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
@en
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
@nl
type
label
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
@en
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
@nl
prefLabel
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
@en
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
@nl
P2093
P1476
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment
@en
P2093
Anuj Goenka
James A Eastham
Juan Martin Magsanoc
Marisa Kollmeier
Michael Schechter
Peter T Scardino
P304
P356
10.1016/J.IJROBP.2011.10.077
P407
P577
2012-01-31T00:00:00Z